Indian Bar Association vs WHO Adv. Dipali Ojha with Rajiv Malhotra

Indian Bar Association vs WHO Adv. Dipali Ojha with Rajiv Malhotra

Advocate Dipali Ojha of the Indian bar association and a team of young indian lawyers have issued a legal notice to the world health organization over their blatant campaign against any alternative treatments. Her legal action against WHO comes after the tweet from Soumya Swaminathan, WHO chief scientist, who issued tweet against Iver-mectin backing it with a link, that was declaration from a private company. The team of indian lawyers seeks to make available all possible affordable options to the masses and hold the highest authorities accountable for their directives , and suspected submission to big pharma lobbying.

Timestamp :

00:00
Intro

01:14
Interview Start

02:03
Dipali Ojha background

03:58
Why did Indian Bar association sue WHO ?

11:08
WHO Scientist Twitter statement against treatments

13:04
History of Iver-mectin & Big Pharma profit motive

16:30
Can 8 billion people get vaccine ? options for poor countries

20:19
Dipali Ohja explains indian Protocol & Lawsuit

23:44
Media blackout on Iver-mectin

24:20
role of fact checkers

25:20
AI bias in social media

26:40
Where was the lawsuit filed?

27:10
Dipahli ojha explains cause of 2nd legal notice

32:38
Effects of legal notice

34:50
Many solutions to the crisis

37:14
Diplai ojha explains the Public Interest Litigation

38:52
Rajiv explains the two lawsuits in one

40:54
Challenging Compulsory Vaccine & civil rights

42:28
Role of Gates Foundation , Fauci & Wuhan lab funding

46:50
Dipali Ohja explains WHO's compromised investigations

48:40
Vaccine and complementary treatments

50:24
Role of AI in information bias

51:19
Closing statement of Diplai Ojha

Links:

http://republicbroadcasting.org/news/indian-bar-association-vs-who-adv-dipali-ojha-with-rajiv-malhotra/

https://rumble.com/vmm54z-indian-bar-association-vs-who-adv.-dipali-ojha-with-rajiv-malhotra.html

https://www.youtube.com/watch?v=eD9BYCYwsUI

http://infinityfoundation.com/

American Journal of Therapeutics
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines